US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.
Astellas is set to buy US-based Audentes Therapeutics for approximately $3 billion, as the Japanese pharmaceutical company looks to boost its gene therapy expertise.
The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.
Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.
DNA testing and analysis company 23andMe has asked the full US Court of Appeals for the Federal Circuit to review an earlier panel decision which held that one of its patents is invalid.
A joint venture between gene-editing startup CRISPR Therapeutics and German pharmaceutical company Bayer will come under the control of CRISPR Therapeutics, according to the pair’s proposed plans.
The US Food and Drug Administration has announced record approvals of generic drugs in 2019, amid growing pressure over drug prices in the US.
A US subsidiary of Chinese genome sequencing company BGI has filed a patent infringement counterclaim against Illumina.
The US Patent and Trademark Office (USPTO) has granted a new CRISPR-Cas9 patent to the University of California (UC), the University of Vienna and Emmanuelle Charpentier, marking the fifth consecutive week that the USPTO has approved a new patent in their CRISPR portfolio.
Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.